1. Home
  2. OMH vs LSTA Comparison

OMH vs LSTA Comparison

Compare OMH & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.80

Market Cap

24.4M

Sector

Finance

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
LSTA
Founded
2015
1980
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
28.9M
IPO Year
2022
2000

Fundamental Metrics

Financial Performance
Metric
OMH
LSTA
Price
$0.80
$3.19
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
17.4K
31.8K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.59
$1.81
52 Week High
$3.25
$5.07

Technical Indicators

Market Signals
Indicator
OMH
LSTA
Relative Strength Index (RSI) 32.26 40.29
Support Level $0.75 $3.02
Resistance Level $1.38 $3.41
Average True Range (ATR) 0.05 0.12
MACD -0.00 0.05
Stochastic Oscillator 11.72 46.64

Price Performance

Historical Comparison
OMH
LSTA

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: